Standout Papers

Circulating microRNAs as stable blood-based markers for cancer detection... 2003 2026 2010 2018 6.4k
  1. Circulating microRNAs as stable blood-based markers for cancer detection (2008)
    Patrick S. Mitchell, Rachael K. Parkin et al. Proceedings of the National Academy of Sciences
  2. Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth (2008)
    Bruce Montgomery, Elahe A. Mostaghel et al. Cancer Research
  3. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer (2003)
    Shunyou Wang, Jing Gao et al. Cancer Cell
  4. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion (2009)
    William Proctor Harris, Elahe A. Mostaghel et al. Nature Clinical Practice Urology
  5. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B (2012)
    Yu Sun, Judith Campisi et al. Nature Medicine
  6. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant (2010)
    Shihua Sun, Cynthia C.T. Sprenger et al. Journal of Clinical Investigation
  7. Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants (2011)
    Elahe A. Mostaghel, Brett T. Marck et al. Clinical Cancer Research
  8. Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer (2012)
    Rong Hu, Changxue Lu et al. Cancer Research
  9. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer (2018)
    Yi-Mi Wu, Marcin Cieślik et al. Cell
  10. Addressing overdiagnosis and overtreatment in cancer: a prescription for change (2014)
    Laura J. Esserman, Ian M. Thompson et al. The Lancet Oncology
  11. In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo (2020)
    Neha N. Parayath, Sirkka B. Stephan et al. Nature Communications
  12. Genomic and phenotypic heterogeneity in prostate cancer (2020)
    Michael C. Haffner, Wilbert Zwart et al. Nature Reviews Urology

Immediate Impact

5 by Nobel laureates 24 from Science/Nature 74 standout
Sub-graph 1 of 21

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout

Works of Peter S. Nelson being referenced

Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy
2019
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout

Author Peers

Author Last Decade Papers Cites
Peter S. Nelson 13020 16759 11583 412 32.1k
Robert L. Vessella 13934 17044 11652 314 31.3k
Martin Gleave 15695 15487 8628 679 32.0k
William B. Isaacs 14479 16765 9045 371 31.9k
Angelo M. De Marzo 13866 16644 10317 437 34.2k
Mark A. Rubin 22807 26319 13092 545 48.4k
John T. Isaacs 8237 10768 3557 303 21.0k
Marco A. Pierotti 5443 13214 5431 450 26.8k
Maria J. Merino 16984 12076 6945 584 36.6k
W. Marston Linehan 21208 22532 13176 581 44.8k
Olli Kallioniemi 7275 19874 11195 419 35.7k

All Works

Loading papers...

Rankless by CCL
2026